Fu, B., Xu, X., & Wei, H. (2020). Why tocilizumab could be an effective treatment for severe COVID-19? Journal of translational medicine, 18(1), 164-5. https://doi.org/10.1186/s12967-020-02339-3
Chicago-Zitierstil (17. Ausg.)Fu, Binqing, Xiaoling Xu, und Haiming Wei. "Why Tocilizumab Could Be an Effective Treatment for Severe COVID-19?" Journal of Translational Medicine 18, no. 1 (2020): 164-5. https://doi.org/10.1186/s12967-020-02339-3.
MLA-Zitierstil (9. Ausg.)Fu, Binqing, et al. "Why Tocilizumab Could Be an Effective Treatment for Severe COVID-19?" Journal of Translational Medicine, vol. 18, no. 1, 2020, pp. 164-5, https://doi.org/10.1186/s12967-020-02339-3.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.